Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 219775
Company: GLAND
Company: GLAND
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/17/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
ACETAZOLAMIDE SODIUM
INJECTABLE;INJECTION; EQ 500MG BASE/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 202693 | AVET LIFESCIENCES |
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 219775 | GLAND |
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 040089 | HIKMA |
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 200880 | MYLAN ASI |
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 040784 | XGEN PHARMS |
| ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 206533 | ZYDUS PHARMS |